StockData
SpyGlass Pharma, Inc. logo

SpyGlass Pharma, Inc. (SGP) stock

SGPNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$31.43−0.81 (-2.50%)

Close on Nov 17, 2026Market cap $1.05BP/E –Yield –

SpyGlass Pharma operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -$41.45M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$41.45M–
FY2024Dec 31, 2024-$27.06M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$21.97M–
Q1 FY2026Mar 31, 2026-$15.41M–
Q2 FY2025Jun 30, 2025-$9.30M–
Q1 FY2025Mar 31, 2025-$7.42M–

More SpyGlass Pharma figures

See a number that looks wrong?